Business Performance Labs (BPL) is a solutions and service provider to pharmaceutical and biotechnology companies, as well as CROs.BPL's "Event Simulation Modeling" (ESM) solution targets the current inefficiencies and challenges in identifying domestic and global sites and investigators for Phases II, III, and IV clinical studies. BPL does this by providing evidence-based results, time-saving ROI, and unparalleled capability for predicting clinical trial outcomes. The ESM suite's initial module – Study Planner & Site Selector (SPSS) – focuses on identifying the optimal sites in the optimal geographies (by state or by country). SPSS allows sponsors to identify sites and investigators for specific studies in less than 1/3 of the time and at a fraction of the cost of conventional methods. Here are exciting results from a recently completed respiratory study:· 111 sites contracted within 4 weeks (w/ 90% coming from US) thereby reducing investigator ID and contracting times by ~ 66%· All sites contracted in time for the kick-off meeting· Within first 3 weeks, over 500 patients screened & 100 randomized (far above goal)· Enrollment time was reduced from over 9 months to 5 months· Patient enrollment was closed 4 months ahead of plan· Estimated costs savings for study – $250,000